NM_004364.5:c.547C>T
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_004364.5(CEBPA):c.547C>T(p.Pro183Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000529 in 1,324,180 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P183T) has been classified as Likely benign.
Frequency
Consequence
NM_004364.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CEBPA | NM_004364.5 | c.547C>T | p.Pro183Ser | missense_variant | Exon 1 of 1 | ENST00000498907.3 | NP_004355.2 | |
| CEBPA | NM_001287424.2 | c.652C>T | p.Pro218Ser | missense_variant | Exon 1 of 1 | NP_001274353.1 | ||
| CEBPA | NM_001287435.2 | c.505C>T | p.Pro169Ser | missense_variant | Exon 1 of 1 | NP_001274364.1 | ||
| CEBPA | NM_001285829.2 | c.190C>T | p.Pro64Ser | missense_variant | Exon 1 of 1 | NP_001272758.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CEBPA | ENST00000498907.3 | c.547C>T | p.Pro183Ser | missense_variant | Exon 1 of 1 | 6 | NM_004364.5 | ENSP00000427514.1 | ||
| ENSG00000267727 | ENST00000587312.1 | n.410G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 | |||||
| CEBPA-DT | ENST00000718467.1 | n.46+69G>A | intron_variant | Intron 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.0000135 AC: 2AN: 148118Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000425 AC: 5AN: 1176062Hom.: 0 Cov.: 33 AF XY: 0.00000694 AC XY: 4AN XY: 576090 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome AF: 0.0000135 AC: 2AN: 148118Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 72110 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Acute myeloid leukemia Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 183 of the CEBPA protein (p.Pro183Ser). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CEBPA-related conditions. ClinVar contains an entry for this variant (Variation ID: 565564). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at